NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TORISEL® Temsirolimus Concentrate for Injection Consumer Medicine
Continue reading »
Novel treatment avenue for resistant cancers: Removing SORLA protein from drug-resistant HER2-positive cancer cell lines
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in
Continue reading »FGF23 hormone from red blood cell precursors promotes hematopoietic stem cell mobilization
A Kobe University research group including graduate student Ishii Shinichi and Associate Professor Katayama Yoshio (both of the Department of
Continue reading »Proteogenomics offers insight to treating head and neck squamous cell carcinoma
Proteogenomic analysis may offer new insight into matching cancer patients with an effective therapy for their particular cancer. A new
Continue reading »Internal clocks drive beta cell regeneration
Certain body parts, such as the skin or liver, can repair themselves after damage. Cell regeneration is the phenomenon by
Continue reading »Scientists closer to finding the cell of origin for ovarian cancer
Researchers at the University of Oxford are now closer to finding the cell of origin of ovarian cancer, and their
Continue reading »Stem cell technology offers new insight into motor neuron disease
Scientists at the University of St Andrews and the University of Edinburgh have identified a specific type of cell in
Continue reading »Omega-3 fatty acids’ health benefit linked to stem cell control, researchers find
For years, researchers have known that defects in an ancient cellular antenna called the primary cilium are linked with obesity
Continue reading »Cell death or cancer growth: A question of cohesion
Activation of CD95, a receptor found on all cancer cells, triggers programmed cell death—or does the opposite, namely stimulates cancer
Continue reading »New screening method identifies inhibitors of cancer cell metabolism
A new screening system developed by scientists at the UCLA Jonsson Comprehensive Cancer Center leverages redundancy in an important component
Continue reading »